Summaries by Inventor Adams, Lucas
VLDLR-based Decoy Receptors to Prevent Alphavirus Infections
Adams, Lucas ; Diamond, Michael ; Fremont, Daved ; Raju, Saravanan
T-020745
Adams, Lucas ; Diamond, Michael ; Fremont, Daved ; VanBlargan, Laura
T-019791
Adams, Lucas ; Diamond, Michael ; Fremont, Daved ; Raju, Saravanan
T-020745
— Published date: 1/14/2026 Value Proposition: Method and composition to potently neutralize EEEV infection. Technology Description Researchers at Washington University in St. Louis have developed very low-density lipoprotein receptor (VLDLR) soluble decoy receptors with potent inhibitory acti…
SARS-CoV-2 neutralizing antibody effective against all variantsAdams, Lucas ; Diamond, Michael ; Fremont, Daved ; VanBlargan, Laura
T-019791
— Disease indication – SARS-CoV-2 infection (COVID-19) Drug format – Chimeric monoclonal antibody Drug class – Best-in-class Research stage and Preliminary data – The inventors have developed and characterized this antibody, creating a chimeric version with a human IgG backbone. T…
